Global Breast Reconstruction Market Size Worth USD 647 million by 2026

The Global Breast Reconstruction Market size is projected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7% from 2021 to 2026.

According to the new market research report "Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7%from 2021 to 2026.

Browse in-depth TOC on " Global Breast Reconstruction Industry"

292- Tables

45- Figures

252- Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593

Breast implants accounted for the largest share of the breast reconstruction industry, by product, in 2020.

Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2020.

By procedure, the immediate procedures segment accounted for the largest market share in 2020.

Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2020. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.

By type, the unilateral segment accounted for the largest industry share in 2020.

Based on type, the breast implant market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share in 2020. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment.

North America was the largest regional segment of the breast reconstruction Industry in 2020.

By region, the breast reconstruction market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and technology advancement and quality improvement leads to FDA approvals for breast reconstruction products

The prominent players operating in the global breast reconstruction market are Mentor Worldwide LLC (Johnson Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil).

Breast Reconstruction Market Growth Drivers

  • Rising incidences of breast cancer
  • Increasing awareness and the availability of reimbursements

Breast Reconstruction Market Growth Opportunities

  • Development of 3D-printed implants

Recent Developments

  • In 2022, Mentor Worldwide LLC (Johnson Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant
  • In 2021, POLYTECH Health Aesthetics received US FDA approval for the company’s textured breast implants (macrotextured and polyurethane-coated implants)
  • In 2020, Sientra received US FDA pre-market approval for its OPUS-branded breast implant products

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=186501593

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: [email protected]


Healthcare101

248 Blog posts

Comments